Explore the benefits of Mochi Health, a telehealth platform offering personalized weight loss solutions and support.

ASHLAND A local family physician and former Ashland School Board member pleaded guilty on Tuesday to federal charges related to the unlawful distribution of weight loss drugs on the ...

PFE's decision to scrap the development of danuglipron comes after a study participant develops potential drug-induced liver injury.

Unprecedented demographic shifts toward an aging population are a defining phenomenon of the 21st century, significantly reshaping the landscape of healthcare delivery and resource allocation. Longer ...

The stock of U.S. pharmaceutical giant Eli Lilly (LLY) is up 3% on news that rival Pfizer (PFE) has ended development of its experimental ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Pfizer said Monday it will halt development of its once-daily obesity pill danuglipron following a safety concern identified ...

Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting ...

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant’s bid to win a slice of ...

Interest in weight-loss medications is at an all-time high, with promising study results and inspiring success stories coming ...

But this is just the start. GLP-1 drugs (specifically Novo Nordisk’s Ozempic, Rybelsus and Wegovy and Eli Lilly’s Mounjaro ...

India’s pharma sector grew by 8.4% during FY25, driven by major chronic therapies, according to market research firm ...